EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The challenge of pelvic aggressive angiomyxoma: case report and literature review

Lucía Villaescusa, Susana López-Celada, Judith Utrilla, Verónica Aranaz, José Onrubia, Francisco Quereda

European Gynecology & Obstetrics · 05.03.2026 · 7 (3)

DOI: 10.53260/ego.257033 ↗

Kurz gefasst

Fallbericht in der Zeitschrift European Gynecology & Obstetrics, online erschienen am 05.03.2026. Verfasst von Lucía Villaescusa und 5 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aggressive angiomyxoma is a rare, histologically benign mesenchymal tumour with infiltrative growth and a high risk of local recurrence, particularly when involving deep pelvic structures. It predominantly affects women of reproductive age and typically arises in the pelviperineal region. Tumour expression of estrogen and progesterone receptors supports a hormonally mediated pathogenesis. We report the case of a 44-year-old woman with a progressively enlarging vulvar–pelvic mass. MRI suggested aggressive angiomyxoma, later confirmed histologically. Surgical excision was performed; however, negative margins could not be achieved because of the tumour’s proximity to critical pelvic organs. Given the hormone-receptor positivity and the high likelihood of residual microscopic disease, adjuvant hormonal suppression with GnRH analogues and aromatase inhibitors was initiated. The patient remains asymptomatic and without radiologic evidence of recurrence on serial MRI during short- to medium-term follow-up. This case illustrates the diagnostic challenges of this uncommon tumour and the difficulty of achieving complete resection without compromising pelvic function. It also underscores the potential role of hormonal therapy as an adjunctive strategy, particularly in premenopausal women, although current evidence remains limited. Long-term monitoring is essential due to the tumour’s indolent course and tendency to recur.

Zitieren

APA

Villaescusa, L., López-Celada, S., Utrilla, J., Aranaz, V., Onrubia, J., & Quereda, F. (2026). The challenge of pelvic aggressive angiomyxoma: case report and literature review. European Gynecology & Obstetrics, 7(3). https://doi.org/10.53260/ego.257033

Vancouver

Villaescusa L, López-Celada S, Utrilla J, Aranaz V, Onrubia J, Quereda F. The challenge of pelvic aggressive angiomyxoma: case report and literature review. European Gynecology & Obstetrics. 2026;7(3). doi:10.53260/ego.257033

BibTeX
@article{Villaescusa2026,
  author = {Villaescusa, Lucía and López-Celada, Susana and Utrilla, Judith and Aranaz, Verónica and Onrubia, José and Quereda, Francisco},
  title = {The challenge of pelvic aggressive angiomyxoma: case report and literature review},
  journal = {European Gynecology & Obstetrics},
  year = {2026},
  volume = {7},
  number = {3},
  doi = {10.53260/ego.257033}
}
Kostenlos starten →